ATE110787T1 - Bestimmung von bakteriuria. - Google Patents
Bestimmung von bakteriuria.Info
- Publication number
- ATE110787T1 ATE110787T1 AT87305254T AT87305254T ATE110787T1 AT E110787 T1 ATE110787 T1 AT E110787T1 AT 87305254 T AT87305254 T AT 87305254T AT 87305254 T AT87305254 T AT 87305254T AT E110787 T1 ATE110787 T1 AT E110787T1
- Authority
- AT
- Austria
- Prior art keywords
- bacteria
- urine
- detected
- examination
- bacteriuria
- Prior art date
Links
- 201000004538 Bacteriuria Diseases 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 5
- 210000002700 urine Anatomy 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 2
- 208000007530 Essential hypertension Diseases 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 238000005119 centrifugation Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 abstract 1
- 229960002227 clindamycin Drugs 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 235000021317 phosphate Nutrition 0.000 abstract 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 239000013049 sediment Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Rehabilitation Therapy (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Eye Examination Apparatus (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP87305254A EP0294529B1 (de) | 1987-06-12 | 1987-06-12 | Bestimmung von Bakteriuria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE110787T1 true ATE110787T1 (de) | 1994-09-15 |
Family
ID=8197944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87305254T ATE110787T1 (de) | 1987-06-12 | 1987-06-12 | Bestimmung von bakteriuria. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0294529B1 (de) |
| AT (1) | ATE110787T1 (de) |
| DE (1) | DE3750474T2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992365A (en) * | 1984-04-23 | 1991-02-12 | Hyman Edward S | Method of detecting bacteria in urine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54119992A (en) * | 1978-03-10 | 1979-09-18 | Lion Dentifrice Co Ltd | Reagent for measuring quantity of bacteria relating to disease around tooth |
| CA1112987A (en) * | 1978-09-25 | 1981-11-24 | Joseph L. Melnick | Staining and analysis of bacteria |
| DE3048294A1 (de) * | 1980-12-20 | 1982-07-08 | Carlos Prof. Dr. 7808 Waldkirch Thomas | "verfahren und vorrichtung zur entwaesserung und/oder entfettung von gewebeproben" |
| HU184903B (en) * | 1981-11-20 | 1984-11-28 | Reanal Finomvegyszergyar | Paint composition for biopsy examinations |
-
1987
- 1987-06-12 AT AT87305254T patent/ATE110787T1/de active
- 1987-06-12 EP EP87305254A patent/EP0294529B1/de not_active Expired - Lifetime
- 1987-06-12 DE DE3750474T patent/DE3750474T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0294529B1 (de) | 1994-08-31 |
| DE3750474D1 (de) | 1994-10-06 |
| DE3750474T2 (de) | 1994-12-22 |
| EP0294529A1 (de) | 1988-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nottebrock et al. | Thymidine concentrations in serum and urine of different animal species and man | |
| Diaz et al. | Bullous pemphigoid antigen: isolation from normal human skin | |
| Lou et al. | A STUDY ON Tea-Pigmentin Prevention of Atherosclerosis | |
| AU3575089A (en) | Method of detecting bacteria in urine | |
| FR2623509B1 (fr) | Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments | |
| DE3205301C2 (de) | ||
| Herz et al. | Acetylcholinesterase Inactivation of Enzymetreated Erythrocytes | |
| Guttman et al. | Significance of cephalin-cholesterol flocculation test in malarial fever | |
| Kirkpatrick Jr et al. | Whipple's disease: a case report with immunological studies | |
| Jepson et al. | Decreased in vivo and in vitro erythropoiesis induced by plasma of ten patients with thymoma, lymphosarcoma, or idiopathic erythroblastopenia | |
| ATE44621T1 (de) | Proteinkonjugate von penicillosaeure, ihre herstellung und verwendung. | |
| DE3750474D1 (de) | Bestimmung von Bakteriuria. | |
| DE3889279D1 (de) | Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B. | |
| AU678343B2 (en) | Method and composition for determining the immunological activity of bioactive substances | |
| EP0070656B1 (de) | Immobilisierte Superoxyd-dismutase, ihre Herstellung und pharmazeutische Zusammensetzung | |
| Speich et al. | Changes in magnesium, zinc, calcium, potassium, cholesterol, and creatine kinase concentrations in patients from pre-infarction syndrome to fatal myocardial infarction. | |
| NO173336C (no) | Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein | |
| Wacek et al. | The peptidoglycan of Pseudomonas solanacearum: chemical composition and biological activity in relation to the hypersensitive reaction in tobacco | |
| AU7059187A (en) | Method for the detection of pregnancy disorders | |
| Burioni et al. | Lyme disease in Italy: isolation of Borrelia burgdorferi from a patient | |
| Williams et al. | Soluble Serum Antigens of P. falciparum in Nigerians | |
| Kamboh et al. | Genetic studies of low-abundance human plasma proteins. I. Microheterogeneity of zinc-α 2-glycoprotein in biological fluids | |
| Horowitz et al. | Blood group substances in canine gastric mucus and acid secretion. | |
| SE8701437D0 (sv) | Diagnostiskt forfarande in vitro samt medel som kan utnyttjas vid forfarandet | |
| Eudy et al. | Renal lysozyme levels in animals developing “sterile pyelonephritis” |